 |
PDBsum entry 1p76
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase, virus/viral protein
|
PDB id
|
|
|
|
1p76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proteins
57:747-757
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding.
|
|
Y.P.Pang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Severe acute respiratory syndrome (SARS) is a contagious and deadly disease
caused by a new coronavirus. The protein sequence of the chymotrypsin-like
cysteine proteinase (CCP) responsible for SARS viral replication has been
identified as a target for developing anti-SARS drugs. Here, I report the
ATVRLQ(p1)A(p1')-bound CCP 3D model predicted by 420 different molecular
dynamics simulations (2.0 ns for each simulation with a 1.0-fs time step). This
theoretical model was released at the Protein Data Bank (PDB; code: 1P76) before
the release of the first X-ray structure of CCP (PDB code: 1Q2W). In contrast to
the catalytic dyad observed in X-ray structures of CCP and other coronavirus
cysteine proteinases, a catalytic triad comprising Asp187, His41, and Cys145 is
found in the theoretical model of the substrate-bound CCP. The simulations of
the CCP complex suggest that substrate binding leads to the displacement of a
water molecule entrapped by Asp187 and His41, thus converting the dyad to a more
efficient catalytic triad. The CCP complex structure has an expanded active-site
pocket that is useful for anti-SARS drug design. In addition, this work
demonstrates that multiple molecular dynamics simulations are effective in
correcting errors that result from low-sequence-identity homology modeling.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Figure 5. Different conformations of the catalytic triad in the
chymotrypsin-like cysteine proteinase.
|
 |
Figure 7.
Figure 7. Overlays of the X-ray structure of the
substrate-bound chymotrypsin-like cysteine proteinase (yellow)
with the corresponding multiple-molecular-dynamics-simulations
model (green) and the corresponding SWISS-MODEL model (red)
(top: residues 183-185; bottom: residues 151-158).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from John Wiley & Sons, Inc.:
Proteins
(2004,
57,
747-757)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
|
| |
For the validation of this model (PDB code:
)
see the following reference:
Dooley AJ, Shindo N, Taggart B, Park JG, Pang YP (2006).
From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus.
Bioorg. Med. Chem. Lett., 16, 830-833.
[PubMed: ]
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.J.Killian,
J.Y.Kravitz,
S.Somani,
P.Dasgupta,
Y.P.Pang,
and
M.K.Gilson
(2009).
Configurational entropy in protein-peptide binding: computational study of Tsg101 ubiquitin E2 variant domain with an HIV-derived PTAP nonapeptide.
|
| |
J Mol Biol,
389,
315-335.
|
 |
|
|
|
|
 |
J.Shi,
J.Sivaraman,
and
J.Song
(2008).
Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease.
|
| |
J Virol,
82,
4620-4629.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Tang,
J.G.Park,
C.B.Millard,
J.J.Schmidt,
and
Y.P.Pang
(2007).
Computer-aided lead optimization: improved small-molecule inhibitor of the zinc endopeptidase of botulinum neurotoxin serotype A.
|
| |
PLoS ONE,
2,
e761.
|
 |
|
|
|
|
 |
K.Zheng,
G.Ma,
J.Zhou,
M.Zen,
W.Zhao,
Y.Jiang,
Q.Yu,
and
J.Feng
(2007).
Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme.
|
| |
Proteins,
66,
467-479.
|
 |
|
|
|
|
 |
N.E.Babady,
Y.P.Pang,
O.Elpeleg,
and
G.Isaya
(2007).
Cryptic proteolytic activity of dihydrolipoamide dehydrogenase.
|
| |
Proc Natl Acad Sci U S A,
104,
6158-6163.
|
 |
|
|
|
|
 |
Q.Wang,
and
Y.P.Pang
(2007).
Preference of small molecules for local minimum conformations when binding to proteins.
|
| |
PLoS ONE,
2,
e820.
|
 |
|
|
|
|
 |
Q.Wang,
and
Y.P.Pang
(2007).
Normal-mode-analysis-monitored energy minimization procedure for generating small-molecule bound conformations.
|
| |
PLoS ONE,
2,
e1025.
|
 |
|
|
|
|
 |
S.B.Le,
M.K.Hailer,
S.Buhrow,
Q.Wang,
K.Flatten,
P.Pediaditakis,
K.C.Bible,
L.D.Lewis,
E.A.Sausville,
Y.P.Pang,
M.M.Ames,
J.J.Lemasters,
E.L.Holmuhamedov,
and
S.H.Kaufmann
(2007).
Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity.
|
| |
J Biol Chem,
282,
8860-8872.
|
 |
|
|
|
|
 |
Y.P.Pang
(2007).
In silico drug discovery: solving the "target-rich and lead-poor" imbalance using the genome-to-drug-lead paradigm.
|
| |
Clin Pharmacol Ther,
81,
30-34.
|
 |
|
|
|
|
 |
Y.P.Pang
(2006).
Novel acetylcholinesterase target site for malaria mosquito control.
|
| |
PLoS ONE,
1,
e58.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |